Stopped: Low enrollment numbers, pharmacy not able to acquire sufficient study article component (methylcellulose) due to manufacturer backorder
The objective of this study is to evaluate the effectiveness of oral naltrexone tablets in pediatric and adolescent eating disorders, in particular anorexia nervosa and bulimia nervosa, as compared to placebo. Study participants will be patients in a partial hospitalization program or intensive outpatient program for eating disorder.
Age range
13 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
ED-15 Score
Timeframe: Time Frame: Measured at the following timepoints: enrollment
ED-15 Score
Timeframe: Time Frame: Measured at the following timepoints: one week
ED-15 Score
Timeframe: Time Frame: Measured at the following timepoints: three week
ED-15 Score
Timeframe: Time Frame: Measured at the following timepoints: six weeks
ED-15 Score
Timeframe: Time Frame: Measured at the following timepoints: nine weeks (last week of treatment)
ED-15 Score
Timeframe: Time Frame: Measured at the following timepoints: 6 months after enrollment